Remove Arrhythmia Remove Defibrillator Remove Sudden Cardiac Death
article thumbnail

Sudden cardiac death after acute myocarditis with arrhythmic presentation: hunting for risk predictors - a systematic review and meta-analysis

Open Heart

Background Ventricular arrhythmias (VAs) frequently occur in the acute phase of myocarditis. Possible arrhythmic recurrences and the risk of sudden cardiac death (SCD) in this setting are reasons for concern, and limited data have been published to guide clinical management of these patients.

article thumbnail

Evaluating real-world mortality risk after defibrillator implantation

The British Journal of Cardiology

Protection against the increased risk of sudden cardiac death (SCD) due to ventricular arrhythmias is offered by the implantation of cardiac defibrillators. This is a single-centre retrospective study on the outcomes of all patients who had a transvenous defibrillator implant in 2015.

article thumbnail

Appropriate use of wearable defibrillators with multiparametric evaluation to avoid unnecessary defibrillator implantation

Open Heart

Introduction Wearable cardioverter-defibrillators (WCD) have emerged as a valuable tool in the management of patients at risk for life-threatening arrhythmias. These devices offer a non-invasive and temporary solution, providing continuous monitoring and the potential for prompt defibrillation when needed.

article thumbnail

Expanded application of wearable cardioverter defibrillators beyond current guidelines: proposal for a European register explained through single clinical scenarios

Open Heart

The wearable cardioverter defibrillator (WCD) is becoming a more and more widely used instrument for the prevention of sudden cardiac death of patients either with a secondary prevention implantable cardioverter defibrillator indication or with a transient high risk of sudden cardiac death.

article thumbnail

MP-470553-004 ADVERSE EVENTS ASSOCIATED WITH WEARABLE CARDIOVERTER-DEFIBRILLATOR (LIFEVEST): A FOOD AND DRUG ADMINISTRATION MAUDE DATABASE STUDY

HeartRhythm

Wearable cardioverter-defibrillator (WCD) is an alternative option for the prevention of sudden cardiac death in patients at high risk for malignant ventricular arrhythmias.

article thumbnail

Why is an Implantable Defibrillator NOT Useful Soon After Myocardial Infarction?

All About Cardiovascular System and Disorders

Here is the transcript of the video: Implantable defibrillator is an important life saving device. It can automatically detect life threatening ventricular arrhythmias and treat them, either with a shock or, sometimes by overdrive pacing. These are high voltage, defibrillator shock coils. So, this is how an ICD works.

article thumbnail

EV ICD Global Pivotal Trial Results Demonstrate High ATP Success, Effective Defibrillation

DAIC

2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and safety of the EV-ICD system. chief medical officer of the Cardiac Rhythm Management business, which is part of the Cardiovascular Portfolio at Medtronic.